KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Deferred Taxes (2016 - 2025)

Charles River Laboratories International has reported Deferred Taxes over the past 17 years, most recently at -$60.2 million for Q4 2025.

  • For Q4 2025, Deferred Taxes fell 45.2% year-over-year to -$60.2 million; the TTM value through Dec 2025 reached -$75.3 million, down 11.66%, while the annual FY2025 figure was -$75.3 million, 11.66% down from the prior year.
  • Deferred Taxes for Q4 2025 was -$60.2 million at Charles River Laboratories International, down from $25.9 million in the prior quarter.
  • Over five years, Deferred Taxes peaked at $25.9 million in Q3 2025 and troughed at -$60.2 million in Q4 2025.
  • A 5-year average of -$12.7 million and a median of -$11.6 million in 2022 define the central range for Deferred Taxes.
  • Biggest five-year swings in Deferred Taxes: soared 477.25% in 2021 and later tumbled 1829.18% in 2025.
  • Year by year, Deferred Taxes stood at -$10.2 million in 2021, then grew by 6.71% to -$9.6 million in 2022, then plummeted by 136.92% to -$22.7 million in 2023, then crashed by 82.94% to -$41.4 million in 2024, then tumbled by 45.2% to -$60.2 million in 2025.
  • Business Quant data shows Deferred Taxes for CRL at -$60.2 million in Q4 2025, $25.9 million in Q3 2025, and -$22.0 million in Q2 2025.